Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Interferon alfa may interfere with the growth of cancer cells.
Combining chemotherapy with interferon alfa may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining temozolomide and interferon
alfa in treating patients who have stage III or stage IV melanoma.